Stay updated on Dexmedetomidine for Schizophrenia Agitation Clinical Trial
Sign up to get notified when there's something new on the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page.

Latest updates to the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.4.3 is added in the page history, replacing the previous v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new history entry 'Revision: v3.4.2' and removed the earlier 'Revision: v3.4.1' entry and the government funding notice from the page history; these are administrative site updates and do not affect study data, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH operations, and updated the release to v3.4.1 (replacing v3.4.0).SummaryDifference0.8%

- Check48 days agoChange DetectedShow glossary toggle and color-coded highlights (green for additions, red for deletions) on the history page. The revision label was updated from v3.3.4 to v3.4.0 and explanatory text about data changes was added.SummaryDifference1%

- Check62 days agoChange DetectedA new revision entry labeled v3.3.4 was added to the Record History.SummaryDifference0.1%

- Check84 days agoChange DetectedA new Revision: v3.3.3 entry was added to the study record history. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

Stay in the know with updates to Dexmedetomidine for Schizophrenia Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page.